Mary Anne Tanay

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

Christopher M. Nutting, James P. Morden, Kevin J. Harrington et al. · The Lancet Oncology · 2011 · 1.7K citations · Full text

Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck

Kevin J. Harrington, Mohan Hingorani, Mary Anne Tanay et al. · Clinical Cancer Research · 2010 · 259 citations

Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies

Eleni Karapanagiotou, Victoria Roulstone, Katie Twigger et al. · Clinical Cancer Research · 2012 · 182 citations · Full text

Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer

Anna M. Kirby, Roger A’Hern, Consuelo D'Ambrosio et al. · British Journal of Cancer · 2006 · 100 citations · Full text

Phase I Study of Lapatinib in Combination With Chemoradiation in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Kevin J. Harrington, Iman El‐Hariry, C. Holford et al. · Journal of Clinical Oncology · 2009 · 78 citations · Full text